LiveSpo Pharma Company Limited

LiveSpo is an R&D, manufacturing, and distribution brand of Spobiotics (probiotics in spore form) for digestive and respiratory health, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for "A Future Without Antibiotics". Our vision: In 2027, LiveSpo will have 1.5 million consumers who use Spore probiotics for digestive and respiratory health instead of antibiotics, with outstanding benefits and customer experiences. Established since 2010 by Dr. Nguyen Hoa Anh (Dr. ANH) and his colleagues, LiveSpo has remained steadfast in its belief that Live Probiotic Spores - Spobiotic - will pave the way to a future without antibiotics for everyone. With a completely different approach from tradition, LiveSpo utilizes probiotic spores to modify the environment and promote the healthy development of the probiotic microbiota. Based on the belief that live probiotic spores will have specific, clear, and "pharmaceutical" functions, LiveSpo has developed a range of specific technologies.